S&P 500   4,531.41 (-0.40%)
DOW   35,587.29 (-0.04%)
QQQ   373.08 (-1.11%)
AAPL   148.88 (-0.40%)
MSFT   308.30 (-0.79%)
FB   322.00 (-5.81%)
GOOGL   2,741.38 (-3.39%)
TSLA   899.42 (+0.61%)
AMZN   3,350.79 (-2.45%)
NVDA   226.61 (-0.14%)
BABA   177.25 (-0.10%)
NIO   39.07 (-2.25%)
CGC   13.36 (-4.84%)
GE   103.69 (+0.52%)
AMD   118.77 (-0.47%)
MU   67.24 (-2.04%)
T   25.55 (-0.82%)
F   16.28 (-1.63%)
ACB   7.10 (-3.66%)
DIS   168.67 (-1.56%)
PFE   42.75 (-0.26%)
BA   213.09 (-0.58%)
AMC   36.39 (-7.26%)
S&P 500   4,531.41 (-0.40%)
DOW   35,587.29 (-0.04%)
QQQ   373.08 (-1.11%)
AAPL   148.88 (-0.40%)
MSFT   308.30 (-0.79%)
FB   322.00 (-5.81%)
GOOGL   2,741.38 (-3.39%)
TSLA   899.42 (+0.61%)
AMZN   3,350.79 (-2.45%)
NVDA   226.61 (-0.14%)
BABA   177.25 (-0.10%)
NIO   39.07 (-2.25%)
CGC   13.36 (-4.84%)
GE   103.69 (+0.52%)
AMD   118.77 (-0.47%)
MU   67.24 (-2.04%)
T   25.55 (-0.82%)
F   16.28 (-1.63%)
ACB   7.10 (-3.66%)
DIS   168.67 (-1.56%)
PFE   42.75 (-0.26%)
BA   213.09 (-0.58%)
AMC   36.39 (-7.26%)
S&P 500   4,531.41 (-0.40%)
DOW   35,587.29 (-0.04%)
QQQ   373.08 (-1.11%)
AAPL   148.88 (-0.40%)
MSFT   308.30 (-0.79%)
FB   322.00 (-5.81%)
GOOGL   2,741.38 (-3.39%)
TSLA   899.42 (+0.61%)
AMZN   3,350.79 (-2.45%)
NVDA   226.61 (-0.14%)
BABA   177.25 (-0.10%)
NIO   39.07 (-2.25%)
CGC   13.36 (-4.84%)
GE   103.69 (+0.52%)
AMD   118.77 (-0.47%)
MU   67.24 (-2.04%)
T   25.55 (-0.82%)
F   16.28 (-1.63%)
ACB   7.10 (-3.66%)
DIS   168.67 (-1.56%)
PFE   42.75 (-0.26%)
BA   213.09 (-0.58%)
AMC   36.39 (-7.26%)
S&P 500   4,531.41 (-0.40%)
DOW   35,587.29 (-0.04%)
QQQ   373.08 (-1.11%)
AAPL   148.88 (-0.40%)
MSFT   308.30 (-0.79%)
FB   322.00 (-5.81%)
GOOGL   2,741.38 (-3.39%)
TSLA   899.42 (+0.61%)
AMZN   3,350.79 (-2.45%)
NVDA   226.61 (-0.14%)
BABA   177.25 (-0.10%)
NIO   39.07 (-2.25%)
CGC   13.36 (-4.84%)
GE   103.69 (+0.52%)
AMD   118.77 (-0.47%)
MU   67.24 (-2.04%)
T   25.55 (-0.82%)
F   16.28 (-1.63%)
ACB   7.10 (-3.66%)
DIS   168.67 (-1.56%)
PFE   42.75 (-0.26%)
BA   213.09 (-0.58%)
AMC   36.39 (-7.26%)
CNSX:MARI

Maricann Group Stock Forecast, Price & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume682,578 shs
Average Volume142,686 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive MARI News and Ratings via Email

Sign-up to receive the latest news and ratings for Maricann Group and its competitors with MarketBeat's FREE daily newsletter.


Maricann Group logo

About Maricann Group

Maricann Group Inc, formerly Danbel Industries Corporation, is a Canada-based integrated producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal license to cultivate cannabis and one of approximately 30 independent licensed producers with a federal license to process and distribute cannabis, the Company's services a patient base with more than 8,000 registered patients. The Company is undertaking an expansion of the cultivation and support facilities to support existing and future patient growth.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
N/A
CIK
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.61 out of 5 stars

Analyst Opinion: 3.3Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Maricann Group (CNSX:MARI) Frequently Asked Questions

Is Maricann Group a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Maricann Group in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Maricann Group stock.
View analyst ratings for Maricann Group
or view top-rated stocks.

What stocks does MarketBeat like better than Maricann Group?

Wall Street analysts have given Maricann Group a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Maricann Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for MARI?

2 Wall Street analysts have issued 1-year price objectives for Maricann Group's shares. Their forecasts range from $4.00 to $5.50. On average, they expect Maricann Group's stock price to reach $4.75 in the next twelve months.
View analysts' price targets for Maricann Group
or view top-rated stocks among Wall Street analysts.

Who are Maricann Group's key executives?

Maricann Group's management team includes the following people:
  • Paul Pathak, Interim Chairman of the Board (Age 49)
  • Michael B. Stein, President, Director
  • Ben Ward, Chief Executive Officer, Interim Chief Financial Officer
  • Geoff Kosar, Vice President - Sales and Marketing

What other stocks do shareholders of Maricann Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Maricann Group investors own include Aurora Cannabis (ACB), VIVO Cannabis (ABCN), Aphria (APHA), Suncor Energy (SU), Suncor Energy (SU), CV Sciences (CVSI), Canopy Growth (WEED), Barkerville Gold Mines Ltd. (BGM.V) (BGM), Cronos Group (CRON) and Emerald Health Therapeutics (EMH).

What is Maricann Group's stock symbol?

Maricann Group trades on the CNSX under the ticker symbol "MARI."

How do I buy shares of Maricann Group?

Shares of MARI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Maricann Group's official website?

The official website for Maricann Group is www.maricann.com.

Where are Maricann Group's headquarters?

Maricann Group is headquartered at 845 Harrington Crt Unit 3, BURLINGTON, ON L7N 3P3, Canada.

How can I contact Maricann Group?

Maricann Group's mailing address is 845 Harrington Crt Unit 3, BURLINGTON, ON L7N 3P3, Canada. The company can be reached via phone at +1-289-2886284.


This page was last updated on 10/22/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.